Clinical Research Directory
Browse clinical research sites, groups, and studies.
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
Sponsor: Kaiser Permanente
Summary
A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-Pump Cardiac Surgery
Official title: NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
304
Start Date
2021-09-13
Completion Date
2025-06-30
Last Updated
2025-03-12
Healthy Volunteers
No
Interventions
Niacinamide
Niacinamide 3 grams on the day of surgery and post-surgical days one and two
Placebo
Matched placebo on the day of surgery and post-surgical days one and two
Locations (1)
Kaiser Permanente San Francisco Medical Center
San Francisco, California, United States